{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:46:01Z","timestamp":1792241161396,"version":"4.4.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Objectives:<\/jats:title>\n                    <jats:p>Movement disorders associated with breast cancer represent heterogeneous paraneoplastic and treatment-related neurological entities. This systematic review aimed to characterize clinical phenotypes, temporal relationships, immunological profiles, treatment strategies, and neurological outcomes of breast cancer\u2013associated movement disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. PubMed, Embase, Scopus, and Google Scholar were searched. Case reports, case series, and cohort studies describing cerebellar syndromes and movement disorders associated with breast cancer in female patients were included. Data were synthesized descriptively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 172 published cases were identified. Cerebellar syndromes accounted for 82\/172 cases (47.7%), with neurological symptoms preceding cancer diagnosis in 63\/82 patients (76.8%). Pancerebellar degeneration was the most frequent phenotype (37\/82, 45.1%), and anti-Yo antibodies predominated (49\/82, 59.8%). Neurological outcomes were poor, with stabilization or deterioration in 50\/82 patients (60.9%) and death in 22\/82 (26.8%). Stiff-person syndrome comprised 34\/172 cases (19.8%), frequently associated with anti-amphiphysin antibodies (23\/34, 67.6%), and demonstrated better outcomes, with marked improvement in 20\/34 patients (58.8%). Parkinsonism and other movement disorders accounted for 38\/172 cases (22.1%) and showed heterogeneous immune-mediated and treatment-related mechanisms. Opsoclonus\u2013myoclonus syndrome was identified in 18\/172 cases (10.5%), most often paraneoplastic (15\/18, 83.3%). Seventeen cohort studies, including 275 patients, confirmed cerebellar ataxia as the predominant phenotype (188\/275, 68.4%), with deterioration or death in 99\/275 patients (36.0%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Breast cancer\u2013associated movement disorders are predominantly immune-mediated, frequently precede cancer diagnosis, and demonstrate phenotype-specific antibody associations and prognostic patterns, underscoring the importance of early recognition and targeted evaluation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aian.aian_75_26","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:00:09Z","timestamp":1780290009000},"page":"336-342","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Movement Disorders Associated With Breast Cancer: A Systematic Review"],"prefix":"10.4103","volume":"29","author":[{"given":"Ravindra K","family":"Garg","sequence":"first","affiliation":[{"name":"Department of Neurology, Era\u2019s Lucknow Medical College and Hospital, Era University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Jain","sequence":"additional","affiliation":[{"name":"Department on Microbiology, All India Institute of Medical Sciences, Rae Bareli, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay A","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Surgery, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Neurology, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Suresh","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Warne Ford Hospital, University of Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Singhal","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, TS Misra Medical College, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"R1-20261017","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/jcm13030824","article-title":"Paraneoplastic neurological syndromes as initial presentation of tumors: An eight-year single-center experience","volume":"13","author":"Melanis","year":"2024","journal-title":"J Clin Med"},{"key":"R2-20261017","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1016\/j.asjsur.2024.05.104","article-title":"A case of breast cancer with paraneoplastic neurological syndrome as the initial presentation","volume":"47","author":"Yang","year":"2024","journal-title":"Asian J Surg"},{"key":"R3-20261017","doi-asserted-by":"crossref","first-page":"e1014","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R4-20261017","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11910-009-0043-4","article-title":"Paraneoplastic movement disorders","volume":"9","author":"Mehta","year":"2009","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R5-20261017","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/brainsci14020176","article-title":"Paraneoplastic cerebellar degeneration associated with breast cancer: A case report and a narrative review","volume":"14","author":"Norrito","year":"2024","journal-title":"Brain Sci"},{"key":"R6-20261017","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0960-9776(03)00011-0","article-title":"Paraneoplastic neurological disorders in breast cancer","volume":"12","author":"Gatti","year":"2003","journal-title":"Breast"},{"key":"R7-20261017","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","article-title":"Paraneoplastic neurological syndromes in the era of immune checkpoint inhibitors","volume":"16","author":"Graus","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"R8-20261017","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archneurol.2011.991","article-title":"Stiff-man syndrome and variants: Clinical course, treatments, and outcomes","volume":"69","author":"McKeon","year":"2012","journal-title":"Arch Neurol"},{"key":"R9-20261017","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/brain\/124.2.437","article-title":"Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus","volume":"124","author":"Bataller","year":"2001","journal-title":"Brain"},{"key":"R10-20261017","first-page":"CRD420251271741","article-title":"Movement disorders in breast cancer: A systematic review","author":"Garg","year":"2025","journal-title":"PROSPERO"},{"key":"R12-20261017","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"BMJ Evid Based Med"},{"key":"R13-20261017","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10549-017-4566-0","article-title":"Breast cancer-related paraneoplastic neurologic disease","volume":"167","author":"Murphy","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"R14-20261017","doi-asserted-by":"crossref","DOI":"10.1093\/jscr\/rjy365","article-title":"Paraneoplastic opsoclonus-myoclonus syndrome as a rare presentation of breast cancer","author":"Martins","year":"2019","journal-title":"J Surg Case Rep 2019"},{"key":"R15-20261017","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12957-021-02436-7","article-title":"Breast cancer-associated opsoclonus-myoclonus syndrome: A case report","volume":"19","author":"Kostoglou","year":"2021","journal-title":"World J Surg Oncol"},{"key":"R16-20261017","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/brainsci11111414","article-title":"Update on paraneoplastic cerebellar degeneration","volume":"11","author":"Loehrer","year":"2021","journal-title":"Brain Sci"},{"key":"R17-20261017","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1172-2-22","article-title":"Paraneoplastic neurological syndromes","volume":"2","author":"Honnorat","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"R18-20261017","doi-asserted-by":"crossref","first-page":"673339","DOI":"10.3389\/fneur.2021.673339","article-title":"Antibody-mediated autoimmune diseases of the CNS: Challenges and approaches to diagnosis and management","volume":"12","author":"Sechi","year":"2021","journal-title":"Front Neurol"},{"key":"R19-20261017","doi-asserted-by":"crossref","first-page":"e200318","DOI":"10.1212\/NXI.0000000000200318","article-title":"Autoimmune encephalitis and paraneoplastic neurologic syndromes: A nationwide study on epidemiology and antibody testing performance","volume":"11","author":"Kerstens","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R20-20261017","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/B978-0-12-823912-4.00015-3","article-title":"Overview of treatment strategies in paraneoplastic neurological syndromes","volume":"200","author":"Kerstens","year":"2024","journal-title":"Handb Clin Neurol"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_75_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:01:07Z","timestamp":1792238467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_75_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_75_26","relation":{},"ISSN":["0972-2327","1998-3549"],"issn-type":[{"value":"0972-2327","type":"print"},{"value":"1998-3549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2026-01-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}